Status:
COMPLETED
Virtual Reality Experiences for Anxiety and Pain Control
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborating Sponsors:
Oregon Health and Science University
Conditions:
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help r...
Detailed Description
PRIMARY OBJECTIVE: I. To measure the impact of a gaming virtual reality (VR) experience compared to a mindfulness VR experience on preoperative anxiety and postoperative pain. OUTLINE: Patients are ...
Eligibility Criteria
Inclusion
- Adults (18 years or older and younger than 89)
- Able to consent
- English-speaking
Exclusion
- Non-English speaking patients because the VR content is only available in English
- Have symptoms concerning for an active respiratory infection or are on contact or isolation precautions
- Any active eye discharge
- A history of seizure, epilepsy, or hypersensitivity to flashing light
- Have a history of motion sickness or vertigo
- Have active nausea or vomiting
- Psychiatric conditions that may interfere with the ability to successfully participate in the study
- Have cardiac pacemakers
- Require hearing aids at all times that cannot be removed
- Have defibrillators
- Have wound dressings on the head or neck that prevent comfortable use of the VR headset
Key Trial Info
Start Date :
March 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04759183
Start Date
March 5 2021
End Date
August 25 2022
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OHSU Knight Cancer Institute
Portland, Oregon, United States, 97239